Skip to main content
SpringerPlus

Table 6 Re-scaled indexes

From: Assessment of technological level of stem cell research using principal component analysis

Indicators

Year

CA

CN

DE

FR

UK

IL

JP

KR

SG

TW

US

Adult stem cell

            

 NP_Patent

1993

0.33a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

1.00

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.04

n/a

0.04

0.05

0.04

0.08

0.10

0.05

0.08

0.05

1.00

 PII_Patent

1993

0.35

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

1.00

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.12

n/a

n/a

1.00

n/a

0.06

0.75

n/a

0.27

n/a

0.36

 NP_Paper

1993

0.03

n/a

0.14

0.11

0.11

0.03

0.16

n/a

n/a

n/a

1.00

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.11

1.00

0.23

0.14

0.18

0.04

0.26

0.27

0.04

0.09

0.93

 PII_Paper

1993

0.09

n/a

0.16

0.12

0.43

0.09

0.08

n/a

n/a

n/a

0.15

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.56

0.26

0.71

0.60

0.84

0.51

0.47

0.47

0.71

0.41

0.76

Embryonic stem cell

            

 NP_Patent

1993

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.01

n/a

n/a

0.01

0.04

0.03

0.13

0.03

0.04

0.01

0.70

 PII_Patent

1993

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

n/a

n/a

n/a

n/a

n/a

n/a

0.67

n/a

0.09

n/a

0.35

 NP_Paper

1993

0.05

n/a

0.16

0.03

0.11

0.03

0.05

n/a

n/a

n/a

0.38

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.04

0.15

0.07

0.03

0.09

0.02

0.07

0.06

0.03

0.01

0.35

 PII_Paper

1993

1.00

n/a

0.13

0.00

0.02

0.06

0.02

n/a

n/a

n/a

0.12

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.51

0.37

0.50

0.63

0.66

0.32

0.46

0.28

0.47

0.18

0.67

Induced pluripotent stem cell

            

 NP_Patent

1993

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

n/a

n/a

n/a

n/a

n/a

n/a

0.05

n/a

n/a

0.01

0.03

 PII_Patent

1993

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

n/a

n/a

n/a

n/a

n/a

n/a

0.59

n/a

n/a

n/a

n/a

 NP_Paper

1993

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.01

0.07

0.02

0.01

0.02

0.01

0.08

0.01

0.00

0.01

0.15

 PII_Paper

1993

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

â‹®

2012

0.88

0.35

0.44

0.94

1.00

0.69

0.37

0.45

0.33

0.58

0.62

  1. CA Canada, CN China, FR France, DE Germany, IL Israel, JP Japan, SG Singapore, KR Korea, TW Taiwan, UK United Kingdom, US United States, NP_Patent number of patents, PII_Patent Patent Impact Index, NP_Paper number of papers, PII_Paper Paper Impact Index
  2. a0.33 is calculated from the result of re-scaling; 1 (NP_Patent of CA in 1993)/3 (NP_Patent of US (maximum value) in 1993)
Back to article page